ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.
TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Department discussion on LAST (Local Anesthetic Systemic Toxicity)
Presented by: Dr. Marisa Baorto
https://www.youtube.com/watch?v=b70Li9r3pL8
Injection of bupivacaine Liposome must not occur within 20 min after the administration of non-bupivacaine local anesthetics, such as lidocaine, because it could cause the immediate release of bupivacaine from the liposome. If the liposomal bupivacaine is injected into the surgical site within 20 min of administration of another non-bupivacaine local anesthetic, the systemic absorption of local anesthetic increases. Bupivacaine HCl, when injected immediately before Exparel, may impact the pharmaco-kinetics of the drugs if the milligram dose of bupivacaine HCl solution exceeds 50% of the Exparel dose. The toxic effects of these drugs are additive.
Different strokes for different folks:
Bupi- more likely to lead to ventricular dysrhythmias.
Other locals- brady, hypotension, asystole or ventricular dysrhythmias
Thereafter, it became evident that bupivacaine differs from other local anesthetics in that it has a narrower margin between the dose or plasma concentration required to produce seizures as compared to those resulting in cardiovascular collapse. 4–6This accrues from the fact that supra convulsant doses of bupivacaine, but not lidocaine or mepivacaine, may induce lethal ventricular arrhythmias out of proportion to the drug's anesthetic potency. 4–6Two theories have been proposed to explain this phenomenon. First, both bupivacaine and lidocaine block cardiac sodium channels rapidly during systole; however, during diastole, bupivacaine dissociates off these channels at a much slower rate than lidocaine. 7As a result, at normal heart rates, diastolic time is sufficiently long for dissociation of lidocaine, but a bupivacaine block intensifies and depresses electrical conduction, causing reentrant type ventricular arrhythmias. Second, high blood concentrations of bupivacaine may cause a ventricular arrhythmia through a direct brainstem effect.”